Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma. Impact of tumor burden on treatment patterns and outcomes in patients with locally advanced or metastatic ...
Neoadjuvant mitomycin C prior to TURBT reduced recurrence risk by 77%, possibly by preventing free-floating cancer cells dislodged during surgery from reimplanting and by increasing local exposure at ...
Surgery for advanced bladder cancer includes transurethral resection of the bladder tumor (TURBT) to remove tumors and cystectomy to remove all or part of the bladder, with the choice depending on the ...
ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following prior therapies for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs). This is ...
En bloc resection is a viable alternative to conventional TURBT, even possibly for large NMIBC and regardless of tumor location. En bloc resection of bladder tumor outperforms transurethral resection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results